AKT1 and hepatocellular carcinoma: The upregulation of glycolytic enzymes is often driven by aberrant activation of the Wnt/β-catenin and PI3K/Akt/mTOR pathways, which are pivotal in HCC’s altered glucose metabolism29,30.